{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:54:27Z","timestamp":1791107667659,"version":"4.1.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.tmaid.2011.12.005","type":"journal-article","created":{"date-parts":[[2012,2,17]],"date-time":"2012-02-17T09:01:25Z","timestamp":1329469285000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Current rabies vaccines and prophylaxis schedules: Preventing rabies before and after exposure"],"prefix":"10.1016","volume":"10","author":[{"given":"M.J.","family":"Warrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.tmaid.2011.12.005_bib1","first-page":"491","article-title":"Neurological complications in adults following rabies vaccine prepared from animal brains","volume":"25","author":"Bahri","year":"1996","journal-title":"Presse Med"},{"issue":"4","key":"10.1016\/j.tmaid.2011.12.005_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14760584.4.4.533","article-title":"Vaccines for lyssaviruses other than rabies","volume":"4","author":"Nel","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tmaid.2011.12.005_bib3","article-title":"Statistics of antirabic inoculations in India","volume":"298","author":"Cornwall","year":"1923","journal-title":"Brit Med J"},{"key":"10.1016\/j.tmaid.2011.12.005_bib4","unstructured":"Veeraraghavan N. Pasteur Institute of Southern India Coonoor. Scientific Report 1968 1 Rabies; 1969, 35\u201380."},{"key":"10.1016\/j.tmaid.2011.12.005_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ije\/16.4.602","article-title":"The diagnostic properties of laboratory tests for rabies","volume":"16","author":"Sitthi-Amorn","year":"1987","journal-title":"Int J Epidem"},{"issue":"Suppl. 4","key":"10.1016\/j.tmaid.2011.12.005_bib6","doi-asserted-by":"crossref","first-page":"S739","DOI":"10.1093\/clinids\/10.Supplement_4.S739","article-title":"Animal models in the pathogenesis and treatment of rabies","volume":"10","author":"Baer","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4269\/ajtmh.1985.34.633","article-title":"Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries","volume":"34","author":"Bernard","year":"1985","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.tmaid.2011.12.005_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/649873","article-title":"Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations","volume":"50","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib9","series-title":"Cell culture rabies vaccines and their protective effect in man","first-page":"160","article-title":"Early\/high and late\/low responders among HDCS vaccines?","author":"Kuwert","year":"1981"},{"issue":"24","key":"10.1016\/j.tmaid.2011.12.005_bib10","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/S0264-410X(00)00054-2","article-title":"Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy","volume":"18","author":"Strady","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.tmaid.2011.12.005_bib11","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1371\/journal.pntd.0000964","article-title":"Elimination of neglected diseases in Latin America and the Caribbean: a mapping of selected diseases","volume":"5","author":"Schneider","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.tmaid.2011.12.005_bib12","first-page":"S30","article-title":"Rabies as a traveler\u2019s risk, especially in high-endemicity areas","volume":"12","author":"Meslin","year":"2005","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.tmaid.2011.12.005_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0035-9203(99)90309-7","article-title":"Immunogenicity and safety of low-dose intradermal rabies vaccination given during an expanded programme on immunization session in Viet Nam: results of a comparative randomized trial","volume":"93","author":"Lang","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.tmaid.2011.12.005_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","article-title":"Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe","volume":"151","author":"Kamoltham","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmaid.2011.12.005_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.trstmh.2007.11.010","article-title":"Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children","volume":"102","author":"Vien","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2011.12.005_bib16","series-title":"WHO expert committee on rabies. Seventh report. Technical report series 709","author":"WHO","year":"1984"},{"key":"10.1016\/j.tmaid.2011.12.005_bib17","series-title":"Manson\u2019s tropical diseases","first-page":"515","article-title":"Travel health","author":"Behrens","year":"2009"},{"issue":"3","key":"10.1016\/j.tmaid.2011.12.005_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2310\/7060.2002.23219","article-title":"Risk of possible exposure to rabies among tourists and foreign residents in Nepal","volume":"9","author":"Pandey","year":"2002","journal-title":"J Travel Med"},{"issue":"1","key":"10.1016\/j.tmaid.2011.12.005_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2310\/7060.2000.00003","article-title":"Survey of rabies preexposure and postexposure prophylaxis among missionary personnel stationed outside the United States","volume":"7","author":"Arguin","year":"2000","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0264-410X(94)00075-X","article-title":"Circumstances and management of 72 animal bites among long-term residents in the tropics","volume":"13","author":"Hatz","year":"1995","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.tmaid.2011.12.005_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tmaid.2007.09.041","article-title":"Assessment of rabies exposure risk among Israeli travelers","volume":"6","author":"Menachem","year":"2008","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0264-410X(91)90221-Q","article-title":"Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost?","volume":"9","author":"Bernard","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4269\/ajtmh.2010.09-0699","article-title":"Rabies exposure risk among foreign backpackers in southeast Asia","volume":"82","author":"Piyaphanee","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2011.12.005_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1471-2334-10-330","article-title":"Travel and migration associated infectious diseases morbidity in Europe, 2008","volume":"10","author":"Field","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib25","first-page":"409","article-title":"Should travellers in rabies endemic areas receive pre-exposure rabies immunization?","volume":"145","author":"Phanuphak","year":"1994","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.tmaid.2011.12.005_bib26","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/j.vaccine.2006.12.034","article-title":"Animal-associated injuries and related diseases among returned travellers: a review of the geosentinel surveillance network","volume":"25","author":"Gautret","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0264-410X(95)00110-M","article-title":"Pre-exposure rabies prophylaxis for the international traveller: a decision analysis","volume":"14","author":"LeGuerrier","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1708-8305.2011.00522.x","article-title":"Rabies postexposure prophylaxis in a UK travel clinic: ten years\u2019 experience","volume":"18","author":"Wijaya","year":"2011","journal-title":"J Travel Med"},{"issue":"Suppl. 4","key":"10.1016\/j.tmaid.2011.12.005_bib29","doi-asserted-by":"crossref","first-page":"S751","DOI":"10.1093\/clinids\/10.Supplement_4.S751","article-title":"Experience with preexposure rabies vaccination","volume":"10","author":"Roumiantzeff","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib30","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/515267","article-title":"Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy","volume":"177","author":"Strady","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/INF.0b013e3181906351","article-title":"A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine","volume":"28","author":"Pengsaa","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2011.12.005_bib32","series-title":"WHO Recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies","author":"WHO","year":"1997"},{"key":"10.1016\/j.tmaid.2011.12.005_bib33","first-page":"425","article-title":"WHO rabies vaccines: WHO position paper","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"RR-3","key":"10.1016\/j.tmaid.2011.12.005_bib34","first-page":"1","article-title":"Human rabies prevention\u2013United States, 2008. Recommendations of the advisory committee on immunization practices (ACIP)","volume":"57","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.tmaid.2011.12.005_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/infdis\/156.1.50","article-title":"Rabies preexposure prophylaxis with human diploid cell rabies vaccine: a dose-response study","volume":"156","author":"Fishbein","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib36","first-page":"25","article-title":"Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design","volume":"351","author":"Teunissen","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.tmaid.2011.12.005_bib37","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(76)93028-2","article-title":"Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small doses","volume":"1","author":"Turner","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2011.12.005_bib38","series-title":"Immunisation against infectious disease","year":"1984"},{"key":"10.1016\/j.tmaid.2011.12.005_bib39","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.vaccine.2008.04.081","article-title":"Intradermal pre-exposure rabies vaccine elicits long lasting immunity","volume":"26","author":"Brown","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1708-8305.1999.tb00524.x","article-title":"Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination","volume":"6","author":"Jaijaroensup","year":"1999","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/jcm.3.2.96-101.1976","article-title":"Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine","volume":"3","author":"Cox","year":"1976","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tmaid.2011.12.005_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1708-8305.2011.00540.x","article-title":"The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule-a case series of 420 travelers","volume":"18","author":"Mills","year":"2011","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1708-8305.2008.00283.x","article-title":"Knowledge, attitudes, and practices of French travelers from Marseille regarding rabies risk and prevention","volume":"16","author":"Altmann","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib44","series-title":"An advisory committee statement (ACS), National advisory committee on immunization (NACI) Canada communicable disease report 31, ACS-5","year":"2005"},{"key":"10.1016\/j.tmaid.2011.12.005_bib45","article-title":"Australian bat lyssavirus infection and rabies","year":"2008"},{"key":"10.1016\/j.tmaid.2011.12.005_bib46","first-page":"767","article-title":"Rabies prevention: supplementary statement on the preexposure use of human diploid cell rabies vaccine by the intradermal route","volume":"35","year":"1986","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmaid.2011.12.005_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2471\/BLT.10.079426","article-title":"Intradermal delivery of vaccines: potential benefits and current challenges","volume":"89","author":"Hickling","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2011.12.005_bib48","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM198601303140504","article-title":"Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine","volume":"314","author":"Pappaioanou","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1708-8305.1999.tb00846.x","article-title":"Intradermal rabies vaccination and concurrent use of mefloquine","volume":"6","author":"Lau","year":"1999","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/oxfordjournals.aje.a120503","article-title":"Avian embryo rabies immunization. 3. Optimal site and timing of intradermal inoculations in pre-exposure regimens","volume":"81","author":"Schnurrenberger","year":"1965","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tmaid.2011.12.005_bib51","first-page":"17","article-title":"Pre-exposure rabies prophylaxis problems and Procedures","volume":"33","author":"Peck","year":"1964","journal-title":"Ind Med Surg"},{"key":"10.1016\/j.tmaid.2011.12.005_bib52","first-page":"309","article-title":"Rabies vaccines: WHO position paper","volume":"85","author":"World Health Organisation","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.tmaid.2011.12.005_bib53","first-page":"278","article-title":"Evaluation of a commercial rabies ELISA as a replacement for serum neutralization assays as part of the pet travel scheme and oral vaccination campaigns of foxes","volume":"123","author":"Knoop","year":"2010","journal-title":"Berl Munch Tierarztl Wochenschr"},{"key":"10.1016\/j.tmaid.2011.12.005_bib54","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-specific antibodies: measuring surrogates of protection against a fatal disease","volume":"4","author":"Moore","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib55","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib56","first-page":"268","article-title":"Vaccine potency requirements for reduced immunization schedules and pre-exposure treatment","volume":"40","author":"Working Group II, WHO Expert Committee","year":"1978","journal-title":"Develop Biol Stand"},{"key":"10.1016\/j.tmaid.2011.12.005_bib57","first-page":"393","article-title":"Rabies prevention\u2013United States, 1984","volume":"33","year":"1984","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmaid.2011.12.005_bib58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2310\/7060.2002.30088","article-title":"The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic","volume":"9","author":"Lau","year":"2002","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tmaid.2004.11.005","article-title":"Intradermal pre-exposure rabies immunisation in New Zealand","volume":"4","author":"Shaw","year":"2006","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5694\/j.1326-5377.2007.tb01128.x","article-title":"Intradermal rabies vaccine","volume":"187","author":"Gherardin","year":"2007","journal-title":"Med J Aust"},{"key":"10.1016\/j.tmaid.2011.12.005_bib61","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jama.1992.03490070052040","article-title":"Poor response to rabies vaccination by the intradermal route","volume":"268","author":"Trimarchi","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2011.12.005_bib62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/313610","article-title":"Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1","volume":"30","author":"Thisyakorn","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib63","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0264-410X(00)00322-4","article-title":"Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination","volume":"19","author":"Thisyakorn","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib64","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1086\/324087","article-title":"Failure of multiple-site intradermal postexposure rabies vaccination in\u00a0patients with human immunodeficiency virus with low CD4+\u00a0T lymphocyte counts","volume":"33","author":"Tantawichien","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1086\/517241","article-title":"Postexposure rabies vaccination in patients infected with human immunodeficiency virus","volume":"28","author":"Jaijaroensup","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib66","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/QAD.0b013e328331a43b","article-title":"Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART","volume":"23","author":"Gelinck","year":"2009","journal-title":"Aids"},{"key":"10.1016\/j.tmaid.2011.12.005_bib67","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1468-1293.2008.00637.x","article-title":"British HIV association guidelines for immunization of HIV-infected adults 2008","volume":"9","author":"Geretti","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib68","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/651267","article-title":"Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus","volume":"50","author":"Maier","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib69","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa043018","article-title":"Transmission of rabies virus from an organ donor to four transplant recipients","volume":"352","author":"Srinivasan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib70","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.vaccine.2011.03.048","article-title":"Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV)","volume":"29","author":"Fayaz","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib71","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4269\/ajtmh.1986.35.663","article-title":"The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine","volume":"35","author":"Fishbein","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2011.12.005_bib72","series-title":"WHO world health organization expert consultation on rabies. First report. WHO technical report series 931","year":"2005"},{"key":"10.1016\/j.tmaid.2011.12.005_bib73","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF01713059","article-title":"High rate of insufficient antibody titers after single-day immunization with human diploid-cell-strain vaccine against rabies","volume":"64","author":"T\u00e4uber","year":"1986","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.tmaid.2011.12.005_bib74","first-page":"765","article-title":"Studies on the local treatment of wounds for the prevention of rabies","author":"Kaplan","year":"1962","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2011.12.005_bib75","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.13.19166-en","article-title":"Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe?","volume":"14","author":"Bourhy","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.tmaid.2011.12.005_bib76","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0092-1157(76)80010-8","article-title":"Neutralizing and complement-fixing antibody responses in pre- and post-exposure vaccines to a rabies vaccine produced in human diploid cells","volume":"4","author":"Kuwert","year":"1976","journal-title":"J Biol Stand"},{"key":"10.1016\/j.tmaid.2011.12.005_bib77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.aje.a112207","article-title":"Immunization schedules for the new human diploid cell vaccine against rabies","volume":"103","author":"Plotkin","year":"1976","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tmaid.2011.12.005_bib78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev.me.29.020178.003055","article-title":"Rabies vaccination","volume":"29","author":"Plotkin","year":"1978","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib79","series-title":"WHO expert committee on rabies. Eighth report. Technical report series 824","author":"WHO","year":"1992"},{"key":"10.1016\/j.tmaid.2011.12.005_bib80","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0264-410X(86)90138-6","article-title":"An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule","volume":"4","author":"Vodopija","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib81","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0264-410X(88)90225-3","article-title":"Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment","volume":"6","author":"Vodopija","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib82","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0264-410X(91)90244-Z","article-title":"One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and vero cell rabies vaccine","volume":"9","author":"Chutivongse","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib83","first-page":"461","article-title":"The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment","volume":"24","author":"Wasi","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.tmaid.2011.12.005_bib84","first-page":"491","article-title":"Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 clinical investigator group","volume":"76","author":"Lang","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2011.12.005_bib85","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.vaccine.2009.09.029","article-title":"Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals","volume":"27","author":"Rupprecht","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib86","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.tmaid.2011.12.005_bib87","unstructured":"Uwanyiligira M, Landry P, Genton B de Valli\u00e8re S. Do travelers receive timely and adequate rabies post-exposure prophylaxis? In: 12th conference of the international society of travel medicine in Boston, May 8\u201312, 2011."},{"key":"10.1016\/j.tmaid.2011.12.005_bib88","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(83)90288-X","article-title":"An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis","volume":"2","author":"Warrell","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2011.12.005_bib89","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(84)91340-0","article-title":"Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens","volume":"1","author":"Warrell","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2011.12.005_bib90","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(85)92367-0","article-title":"Economical multiple-site intradermal immunisation with human diploid- cell-strain vaccine is effective for post-exposure rabies prophylaxis","volume":"i","author":"Warrell","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2011.12.005_bib91","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S0950268800066619","article-title":"Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis","volume":"99","author":"Suntharasamai","year":"1987","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.tmaid.2011.12.005_bib92","first-page":"145","article-title":"Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies","volume":"14","author":"Madhusudana","year":"2001","journal-title":"Natl Med J India"},{"key":"10.1016\/j.tmaid.2011.12.005_bib93","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1201-9712(02)90113-X","article-title":"Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals","volume":"6","author":"Madhusudana","year":"2002","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib94","series-title":"Report of informal discussions on intra-dermal application of modern rabies vaccines for human post-exposure treatment","author":"WHO","year":"1993"},{"key":"10.1016\/j.tmaid.2011.12.005_bib95","first-page":"33","article-title":"Humoral and cell-mediated immune responses to various economical regimens of purified vero cell rabies vaccine","volume":"5","author":"Phanuphak","year":"1987","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.tmaid.2011.12.005_bib96","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0140-6736(90)90488-Q","article-title":"Postexposure prophylaxis for rabies with antiserum and intradermal vaccination","volume":"335","author":"Chutivongse","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2011.12.005_bib97","series-title":"WHO Expert Committee on rabies. Eighth report. Technical report series 824","year":"1992"},{"key":"10.1016\/j.tmaid.2011.12.005_bib98","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0264-410X(94)90308-5","article-title":"A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis","volume":"12","author":"Suntharasamai","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib99","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijid.2003.07.001","article-title":"Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai red cross regimen","volume":"8","author":"Madhusudana","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib100","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2011.12.005_bib101","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1\u00a0ml PCEC rabies vaccine administered intradermally using the Thai red cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambao","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib102","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/hv.2.5.3197","article-title":"Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai red cross intradermal regimen at a dose of 0.1\u00a0ml","volume":"2","author":"Madhusudana","year":"2006","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.tmaid.2011.12.005_bib103","doi-asserted-by":"crossref","first-page":"8647","DOI":"10.1016\/j.vaccine.2007.10.004","article-title":"An important date in rabies history","volume":"25","author":"Dodet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib104","doi-asserted-by":"crossref","first-page":"383870","DOI":"10.4061\/2011\/383870","article-title":"Human rabies in the WHO southeast Asia region: forward steps for elimination","volume":"2011","author":"Gongal","year":"2011","journal-title":"Adv Prev Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib105","doi-asserted-by":"crossref","first-page":"e982","DOI":"10.1371\/journal.pntd.0000982","article-title":"Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries","volume":"5","author":"Hampson","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib106","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.vaccine.2004.12.008","article-title":"The real cost of rabies post-exposure treatments","volume":"23","author":"Goswami","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib107","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1371\/journal.pntd.0000224","article-title":"A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods","volume":"2","author":"Warrell","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib108","first-page":"15","article-title":"Immunogenicity and safety of three intradermal anti-rabies vaccination regimens using purified vero cell rabies vaccine","volume":"10","author":"Quiambao","year":"2008","journal-title":"APCRI J"},{"key":"10.1016\/j.tmaid.2011.12.005_bib109","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1016\/j.vaccine.2006.02.036","article-title":"Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen","volume":"24","author":"Ambrozaitis","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/649211","article-title":"Postexposure rabies prophylaxis completed in 1 week: preliminary study","volume":"50","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib111","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.vaccine.2009.02.012","article-title":"Report of the fifth AREB meeting Ho Chi Minh City, Vietnam, 17\u201320 November 2008","volume":"27","author":"Dodet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib112","first-page":"753","article-title":"Commentary. Proposed new rabies control guidelines (highlights from the WHO consultation on human and dog\u00a0rabies prevention and control, Veryier du lac, France, 7\u20139 October, 2009","volume":"3","year":"2009","journal-title":"Asian Biomed"},{"key":"10.1016\/j.tmaid.2011.12.005_bib113","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S0022172400070583","article-title":"Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization","volume":"89","author":"Turner","year":"1982","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.tmaid.2011.12.005_bib114","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0264-410X(00)00342-X","article-title":"Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons","volume":"19","author":"Briggs","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib115","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1086\/513760","article-title":"Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations","volume":"25","author":"Kositprapa","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib116","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1708-8305.1999.tb00844.x","article-title":"Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously","volume":"6","author":"Naraporn","year":"1999","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib117","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.vaccine.2006.02.027","article-title":"Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity","volume":"24","author":"Suwansrinon","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib118","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1086\/514737","article-title":"Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine","volume":"28","author":"Tantawichien","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib119","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2310\/7060.2002.23189","article-title":"Four-site intradermal postexposure boosters in previously rabies vaccinated subjects","volume":"9","author":"Khawplod","year":"2002","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib120","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/656585","article-title":"A 4-site, single-visit intradermal postexposure prophylaxis regimen for previously vaccinated patients: experiences with >5000 patients","volume":"51","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib121","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tmaid.2007.07.004","article-title":"Preventing rabies with the verorab vaccine: 1985\u20132005 twenty years of clinical experience","volume":"5","author":"Toovey","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib122","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.vaccine.2007.02.075","article-title":"Safety review of the purified chick embryo cell rabies vaccine: data from the vaccine adverse event reporting system (VAERS), 1997\u20132005","volume":"25","author":"Dobardzic","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib123","first-page":"319","article-title":"Passive immunization","volume":"vol. II","author":"Cabasso","year":"1975"},{"key":"10.1016\/j.tmaid.2011.12.005_bib124","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.trstmh.2006.04.009","article-title":"Sex- and age-related differences in rabies immunoglobulin hypersensitivity","volume":"101","author":"Suwansrinon","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2011.12.005_bib125","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"Muller","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib126","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","article-title":"Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates","volume":"25","author":"Sloan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib127","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","article-title":"A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis","volume":"58","author":"de Kruif","year":"2007","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.tmaid.2011.12.005_bib128","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-12-387040-7.00016-0","article-title":"Design of future rabies biologics and antiviral drugs","volume":"79","author":"Smith","year":"2011","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.tmaid.2011.12.005_bib130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4161\/hv.7.3.14207","article-title":"Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond","volume":"7","author":"Yusibov","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.tmaid.2011.12.005_bib131","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1073\/pnas.0832472100","article-title":"Function and glycosylation of plant-derived antiviral monoclonal antibody","volume":"100","author":"Ko","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmaid.2011.12.005_bib132","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"Hultberg","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tmaid.2011.12.005_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2011.09.002","article-title":"Nanobodies\u00ae: new ammunition to battle viruses","author":"Vanlandschoot","year":"2011","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2011.12.005_bib134","first-page":"77","article-title":"Delivery systems for intradermal vaccination","volume":"351","author":"Kim","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.tmaid.2011.12.005_bib135","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.vaccine.2010.06.062","article-title":"Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults","volume":"28","author":"Laurent","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib136","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1182\/blood-2009-03-211052","article-title":"Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans","volume":"114","author":"Blanchard-Rohner","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tmaid.2011.12.005_bib137","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.4049\/jimmunol.1000844","article-title":"NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination","volume":"185","author":"Horowitz","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.tmaid.2011.12.005_bib138","unstructured":"Guinet-Morlot F, Pichon S, Sarcey E, Calvosa E, Chevalier M. Development and characterization of the next generation of purified Vero rabies vaccine (PVRV). XXI international meeting on rabies in the Americas, Guadalajara, Mexico; 2010."},{"key":"10.1016\/j.tmaid.2011.12.005_bib139","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1586\/erv.10.105","article-title":"Experimental rabies vaccines for humans","volume":"9","author":"McGettigan","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tmaid.2011.12.005_bib140","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.vaccine.2011.03.104","article-title":"Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies","volume":"29","author":"Wu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib141","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/605949","article-title":"Replication- deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates","volume":"200","author":"Cenna","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib142","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0264-410X(89)90152-7","article-title":"Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization","volume":"7","author":"Dreesen","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib143","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00000441-198705000-00003","article-title":"Rabies pre-exposure prophylaxis using intradermal human diploid cell vaccine: immunologic efficacy and cost-effectiveness in a university medical center and a review of selected literature","volume":"293","author":"Morrison","year":"1987","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.tmaid.2011.12.005_bib144","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1086\/520143","article-title":"A new vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children","volume":"29","author":"Sabchareon","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2011.12.005_bib145","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2460\/javma.1983.183.12.1468","article-title":"Antibody response to a single intradermal booster dose of rabies human diploid cell vaccine","volume":"183","author":"Dreesen","year":"1983","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.tmaid.2011.12.005_bib146","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00006454-199811000-00007","article-title":"Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified vero cell rabies vaccine","volume":"17","author":"Sabchareon","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2011.12.005_bib147","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/hv.3.5.4216","article-title":"Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccination","volume":"3","author":"Morris","year":"2007","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.tmaid.2011.12.005_bib148","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(92)90029-J","article-title":"Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine","volume":"10","author":"Briggs","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2011.12.005_bib149","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2460\/javma.1987.191.02.185","article-title":"Antibody response after a two-year intradermal booster of rabies human diploid cell vaccine","volume":"191","author":"Horman","year":"1987","journal-title":"J Am Vet Med Assoc"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147789391100130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147789391100130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:58:42Z","timestamp":1761487122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147789391100130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S147789391100130X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2011.12.005","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current rabies vaccines and prophylaxis schedules: Preventing rabies before and after exposure","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2011.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}